From Antibodies to TCRs: The Next Wave of Innovative Biologics
Recently, Dr. Wenbo Wang, CEO of Lealing Bio, attended the 9th Biocytogen Model Animal and Pharmaceutical Industry Conference as a keynote speaker. He delivered an insightful presentation titled “From Antibodies to TCRs: The Next Wave of Innovative Biologics.”
